LONDON, U.K., CAMBRIDGE, U.K, and BOSTON, Mass., Feb. 13, 2018 — Cancer Research UK and Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) product platform, announced today that the first pa...